KRAS and cancer: Other synthetic oleanane triterpenoids were found to inhibit tumorigenesis by inhibiting the transcription of oncogenes, including k-RAS, TP53, BRCA1, and Erb-B2 receptor tyrosine kinase 2, in some cancers [52,53].